Business Context and Reporting Period
Company: Ultralife Batteries, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended December 31, 1997 (Fiscal Year 1998).
Business Overview: The company manufactures and sells primary and rechargeable batteries and technology contracts. Key products include 9-volt batteries for smoke detectors and BA-5372 batteries for the US Army. The company is currently expanding facilities for high-volume production of rechargeable batteries.
Key Financial Metrics
| Metric | Six Months Ended Dec 31, 1997 | Six Months Ended Dec 31, 1996 |
|---|---|---|
| Total Revenue | $8,998,825 | $8,037,766 |
| Gross Profit | $1,255,293 | $417,401 |
| Gross Margin | 14.0% | 5.2% |
| Operating Loss | $(3,233,219) | $(4,156,532) |
| Net Loss | $(2,827,793) | $(3,355,654) |
| Loss Per Share (Basic) | $(0.36) | $(0.42) |
| Cash and Equivalents (End of Period) | $2,773,768 | $183,193 |
| Total Investments (Available-for-sale) | $13,148,403 | $19,847,201 |
| Long-Term Debt | $0 | $0 |
Liquidity: As of December 31, 1997, total liquid assets (cash, cash equivalents, and available-for-sale securities) totaled approximately $15.9 million. The company maintains a limited line of credit of $370,000 for its UK subsidiary but has no long-term debt.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased by approximately 12% ($961,000) year-over-year. This was driven by a 21% increase in sales of 9-volt and BA-5372 primary batteries and a 140% increase in technology contract revenues (attributed to an agreement with Mitsubishi).
- Margin Improvement: Gross margin improved significantly from 5.2% to 14.0% due to higher production volumes of 9-volt batteries and manufacturing efficiencies. Cost of products sold as a percentage of revenue decreased from 95% to 86%.
- Operating Expenses: Operating expenses decreased slightly ($85,400) despite a significant increase in Research & Development (R&D) spending ($1.28 million increase). R&D increased to accelerate the commercialization of advanced rechargeable batteries. Selling, General, and Administrative (SG&A) expenses decreased due to cost control efforts.
- Insurance Proceeds: Operating expenses were reduced by $1,195,427 due to insurance proceeds received for leasehold improvements written off following a fire at the UK subsidiary in December 1996.
- Interest Income: Interest income decreased by $373,700 as the company utilized cash and investments to fund operations and capital equipment additions.
Guidance, Outlook, Risks, and Contingencies
- Capital Expenditures: The company spent $5.7 million on property and equipment year-to-date. An additional $2.9 million is expected to be required in the third quarter of fiscal 1998 to complete a fully automated production line for rechargeable batteries.
- Outlook: Management believes the current financial position is adequate to support near-term requirements. However, continued sales growth and expansion may necessitate exploring normal working capital lines of credit.
- Contingency (China Battery): A significant contingency exists regarding a manufacturing facility in China. The Chinese partner, Changzhou Ultra Power Battery Co., Ltd., owes approximately $400,000 (balance of a $6.0 million contract) and has demanded reimbursement of losses. The company wrote down the balance and investment in fiscal 1997 but notes that a successful claim by the partner could adversely affect financial condition.
- UK Subsidiary: Operations at the Abingdon, England facility were suspended due to a fire in December 1996, impacting sales of high-rate batteries. Production has resumed, but the fire continues to influence comparative results.
Investor Verification Checklist
- Capital Burn Rate: Verify the sufficiency of the $15.9 million in liquid assets to cover the projected $2.9 million capital expenditure and ongoing operating losses.
- China Contingency: Assess the legal status of the dispute with Changzhou Ultra Power Battery Co., Ltd. and the potential financial impact of their claim for reimbursement.
- R&D Commercialization: Monitor the timeline and success of the advanced rechargeable battery commercialization efforts, which are driving increased R&D costs.
- UK Recovery: Confirm the full operational recovery and sales normalization of the UK subsidiary following the 1996 fire.
- Debt Financing: Watch for announcements regarding new working capital lines of credit as the company scales production.